Pharmaceutical Executive November 5, 2024
Miranda Schmalfuhs

The latest news for pharma industry insiders.

A Strategic Look at FDA’s Diversity Action Plan Guidance

In a video interview with Applied Clinical Trials, Jay Park and Rebecca Metcalfe of Core Clinical Sciences discussed their recent article published in JAMA titled, “Diversity Action Plans in Clinical Trials.” In addition to key takeaways from the article, Park and Metcalfe discussed the FDA’s new guidance for diversity action plans in clinical trials, the role of risk-based monitoring as a tool for improving diversity, and the importance of patient-reported outcomes.

Combatting Medical Misinformation: Strategies for Patient Education, Curriculum Integration, and Social Media Engagement

Pharmacy Times interviewed Julie Sibbesen, PharmD, a clinical pharmacy specialist in Enterprise Medication Use at WVU Medicine in Morgantown, West...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
STAT+: 7 companies to watch in AI protein design
STAT+: Pharmalittle: We’re reading about Medicaid coverage of obesity drugs, a death in a sickle cell trial, and more
Novo puts $285m into monthly GLP-1 based on Ascendis tech
Nudging The Way Forward Into The Future Of Healthcare Marketing
Removing Need for Switching Studies Could Change Payer Perspectives of Biosimilars

Share This Article